SUMO3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.441800E-01
Normal-vs-Stage2
4.649800E-01
Normal-vs-Stage3
6.893800E-01
Normal-vs-Stage4
2.494500E-02
Stage1-vs-Stage2
2.085800E-01
Stage1-vs-Stage3
5.077000E-01
Stage1-vs-Stage4
2.824000E-02
Stage2-vs-Stage3
9.510200E-01
Stage2-vs-Stage4
2.724800E-01
Stage3-vs-Stage4
6.062000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.039000E-01
Normal-vs-AfricanAmerican
3.238600E-01
Normal-vs-Asian
9.536600E-01
Caucasian-vs-AfricanAmerican
4.874600E-01
Caucasian-vs-Asian
2.557000E-01
AfricanAmerican-vs-Asian
2.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.434400E-01
Normal-vs-Female
4.492800E-01
Male-vs-Female
9.727200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.810200E-01
Normal-vs-Age(41-60Yrs)
2.956000E-01
Normal-vs-Age(61-80Yrs)
6.340600E-01
Normal-vs-Age(81-100Yrs)
2.129200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.979800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.135400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.256800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.202170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.974800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.108200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.834800E-01
Normal-vs-Daily Drinker
8.665000E-01
Normal-vs-Weekly Drinker
5.070600E-01
Normal-vs-Occasional Drinker
1.593560E-01
Normal-vs-Social Drinker
5.181000E-01
Non Drinker-vs-Daily Drinker
7.557000E-01
Non Drinker-vs-Weekly Drinker
4.219000E-01
Non Drinker-vs-Occasional Drinker
8.754200E-02
Non Drinker-vs-Social Drinker
5.469600E-01
Daily Drinker-vs-Weekly Drinker
3.977000E-01
Daily Drinker-vs-Occasional Drinker
1.006000E-01
Daily Drinker-vs-Social Drinker
4.819600E-01
Weekly Drinker-vs-Occasional Drinker
6.047400E-01
Weekly Drinker-vs-Social Drinker
8.407800E-01
Occasional Drinker-vs-Social Drinker
3.987200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.676200E-01
Normal-vs-Grade 2
1.157990E-02
Normal-vs-Grade 3
1.202480E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.619350E-04
Grade 1-vs-Grade 3
9.51230000000303E-05
Grade 1-vs-Grade 4
2.676200E-01
Grade 2-vs-Grade 3
2.004800E-01
Grade 2-vs-Grade 4
1.157990E-02
Grade 3-vs-Grade 4
1.202480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.956800E-01
Normal-vs-NonDiabetic
5.050000E-01
Diabetic-vs-NonDiabetic
5.660400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.004200E-01
Normal-vs-NoPancreatitis
5.492200E-01
Pancreatitis-vs-NoPancreatitis
5.060600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.325600E-01
Normal-vs-N1
4.390000E-01
N0-vs-N1
5.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.172380E-01
Normal-vs-TP53-NonMutant
8.096000E-01
TP53-Mutant-vs-TP53-NonMutant
4.21230000000605E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
